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• l-histidine has an anxiolytic-like effect on mice exposed to the elevated plus-maze test.
• CPA reverses the anxiolytic-like effect caused by l-histidine.
• The dorsal hippocampus’s H1 receptors are involved in emotional memory of mice.
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a b s t r a c t
Severalﬁndingshavepointed to the roleofhistaminergicneurotransmission in themodulationof anxiety-
like behaviors and emotional memory. The elevated plus-maze (EPM) test has been widely used to
investigate the process of anxiety and also has been used to investigate the process of learning and
memory. Visual cues are relevant to the formation of spatial maps, and as the hippocampus is involved
in this task, experiment 1 explored this issue. Experiment 2 investigated the effects of intraperitoneal
(i.p.) injections of l-histidine (LH, a precursor of histamine) and of intra-dorsal hippocampus (intra-DH)
injections of chlorpheniramine (CPA, an H1 receptor antagonist) on anxiety and emotional memory in
mice re-exposed to the EPM. Mice received saline (SAL) or LH i.p. and SAL or CPA (0.016, 0.052, and
0.16nmol/0.1l) intra-DH prior to Trial 1 (T1) and Trial 2 (T2). No signiﬁcant changes were observed in
the number of enclosed-arm entries (EAE) in T1, an EPM index of general exploratory activity. LH had an
anxiolytic-like effect that was reversed by intra-DH injections of CPA. T2 versus T1 analysis revealed that
only the lower dose of CPA resulted in impaired emotional memory. Combined injections of LH and CPA
revealed that higher doses of CPA impair emotional memory. Taken together, these results suggest that
LH and H1 receptors present in the dorsal hippocampus are involved in anxiety-related behaviors and
emotional memory in mice submitted to EPM.
© 2014 Elsevier Ireland Ltd. All rights reserved.
1. Introduction
Emotional memory may be modulated by experiences occur-
ring at the time when it is learned (acquisition), consolidated, or
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retrieved [3] and a modulatory system involved in these memory
processes may be the histaminergic system [2].
The actions of histamine are mediated by four distinct subtypes
of G-protein-coupled receptors: H1–H4 [15,30]. The central his-
taminergic nervous system originates from the tuberomammillary
nucleus of the posterior hypothalamus, and it innervates almost
the whole brain, including the hippocampus, which is innervated
by two histaminergic ﬁber bundles through the fornix and caudal
route [15].
Histamine also regulates a variety of neurobiological functions
and behavioral responses [for review see [2,15]], including anxiety
[33]. When histaminergic agents are microinjected into the hip-
http://dx.doi.org/10.1016/j.neulet.2014.12.020
0304-3940/© 2014 Elsevier Ireland Ltd. All rights reserved.
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pocampus of a rat, they may modulate anxiety via the H1 and H2
receptors in an elevated plus-maze (EPM) test of anxiety [26,33],
and they enhance memory consolidation through the activation of
H2 in an inhibitory avoidance test [8].
The EPM test is an animal model of anxiety based on rodents’
natural aversion to open spaces [18,25]. Further, the EPM has been
used to investigate the process of learning and memory based on
exploratory behavior during EPM re-exposure [6,10,12,13,27,28].
After being confronted with evidence of the involvement of the
dorsal hippocampus (DH) of rats in anxiety andmemory,which has
histaminergic projections [15,33], the present study was designed
to investigate the role of the histaminergic system on anxiety
and emotional memory of mice via i.p. injections of l-histidine
and intra-dorsal hippocampus (intra-DH) injections of chlorpheni-
ramine using a Trial 1/2 protocol in the EPM. The present study
investigated if l-histidine would have anxiolytic and/or memory
impairment and if these putative effects would be reversed by
chlorpheniramine.
2. Materials and methods
2.1. Animals
Male Swiss mice (UFSCar SP, Brazil), weighing 25–35g were
maintained under a 12h light cycle in a controlled environment
at 23±1 ◦C. The experimental sessions were conducted during the
light period of the cycle (11:00–15:00h).
2.2. Drugs
l-Histidine monohydrochloride monohydrate (LH) and the H1
receptor antagonist chlorpheniramine maleate salt (CPA) (Sigma,
MO, USA) were prepared in vehicle of physiological saline (SAL).
The doses were based on previous study [28].
2.3. First experiment
Once our experimental room included the presence of different
visual cues, such as windows and laboratory benches, we investi-
gated if animals use environmental cues to remember andavoid the
open arms of the EPM. In this context, we exposed and re-exposed
two naïve independent groups of animals to the EPM under differ-
ent conditions: without (n=12) or with (n=15) an opaque black
curtain placed around the EPM. The illumination levels in the cen-
tral area of the EPM were 86 (without) and 50 (with curtain) lux.
The apparatus consisted of two open arms (30×5×0.25 cm) and
twoenclosed arms (30×5×15 cm) connected to a common central
platform (5×5 cm). The maze was made of crystal acrylic and was
raised to a height of 38.5 cm above ﬂoor level.
2.4. Second experiment—stereotaxic surgery and microinjections
Mice were anesthetized by i.p. injection of ketamine hydrochlo-
ride (50mg/kg) plus xylazine (5mg/kg) and were then placed in a
stereotaxic instrument. The stereotaxic coordinates for injection
into the DH were as follows: −1.8mm anterior to the bregma,
±1.6mm lateral to the midline, and −1.5 ventral to skull surface,
according to brain atlas [23]. The stainless steel guide cannula
(25-gauge) was implanted bilaterally in the DH, 1mm above the
injection site. It was then ﬁxed to the skull with acrylic dental
cement. Postoperative analgesicwasprovided according toMessier
et al. [20].
Intra-DH injections were performed by means of an inter-
nal cannula (33-gauge) terminating 1mm below the tip of the
guides and connected by polyethylene tubing (PE-10) to a 5-l
Hamilton syringe. Administration was controlled by an infusion
pump programmed to deliver a volume of 0.1l over a 60-s
period (0.2l/mouse). The microinjection procedure was followed
according to previous studies [11,27].
2.5. Evaluation of anxiety (T1) and evaluation of emotional
memory (T2)
On the ﬁfth day after surgery, the animalswere submitted to the
EPM test. For T1, mice were pre-treated i.p. with SAL or LH. Two
hours after the systemic injection [27], the animals were treated
with intra-DH microinjections of SAL or CPA (0.016, 0.052 and
0.16nmol/0.1l). Five minutes after the central microinjections,
the mice were individually placed on the central platform of the
maze facing the open arm and were allowed to explore the maze
for 5min. Twenty-four hours after T1, the mice were submitted to
the same protocol described above (Fig. 2B).
2.6. Behavioral analysis
The behavioral parameters [24] were the following: the fre-
quency of open- and enclosed-armentries (EAE) and the total times
spent in the open arms and central area. These data were used to
calculate the percentage of: open-arm entries (%OAE), time spent
in the open arms (%OAT) and time spent in the central area (%CT).
The number of stretched-attend postures (SAP) and the frequency
of head dipping (exploratorymovement of head/shoulders over the
sides of the maze) were also scored. The total SAP was considered
to be a primary index of risk assessment, and head dipping was
considered to be an index of exploratory behavior [25]. EAE were
used as a locomotor activity measure [7].
Data for the above measures are reported both as behavior
totals (e.g., SAP) and as “percent protected” scores (e.g., %pSAP)
[24]. Anxiety-related behaviors and emotional memory were eval-
uated by the T1/T2 paradigm [1,12,28]. Anxiety was evaluated
through open-arm exploration measures in T1. Reduction in open-
arm exploration in T2was used as a learning andmemory response
[4,6,12,13,27,28].
2.7. Histology
At the end of testing, animals received a 0.1-l infusion of
1% methylene blue according to the microinjection procedure
describedabove. Theanimals receivedananesthetic overdose, their
brains were removed, and the injection sites were veriﬁed histo-
logically according to the mouse brain atlas [23].
2.8. Statistical analysis
For the ﬁrst experiment, the data were analyzed using a two-
wayANOVAwith repeatedmeasures [Factor 1 (F1):without orwith
curtain; Factor 2 (F2): T1 and T2]. The second experiment was ana-
lyzed with a three-way ANOVA with repeated measures (F1: i.p.
administration of SAL or LH; F2: central microinjections of SAL or
CPA; Factor 3 (F3): T1 and T2). When differences were indicated by
signiﬁcant Fvalues, theywere identiﬁedbyDuncan’s test. Ap≤0.05
was required to indicate signiﬁcance.
3. Results
3.1. First experiment
ANOVA demonstrated a signiﬁcant difference between the two
conditions (F1(1,25) =12.80), trials (F2(1,25) =4.62) and a tendency
of interaction between factors (F1 × F2(1,25) =3.57, p=0.07) for
%OAE.Duncan’s test pointed to an increase in%OAEofmice exposed
to the EPM with a curtain in T1 as compared with animals exposed
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to the EPM without curtain (Fig. 1 ). Duncan’s test also revealed
a decrease in the %OAE for mice submitted to the EPM with a
curtain in T2 as compared with T1 under the same conditions.
Similar results were demonstrated by statistical analysis of %OAT
(F1(1,25) =19.64; F2(1,25) =2.36 and F1 × F2(1,25) =10.66) (Fig. 1B).
ANOVA revealed no signiﬁcant differences of EAE between
the two conditions (F1(1,25) =0.19) and factor interactions
(F1 × F2(1,25) =2.08). However, a signiﬁcant difference was found
between trials (F2(1,25) =8.26), as shown by an increase in EAE in
T2 for mice submitted to the EPM with a curtain (Fig. 1C). Based
on these data, we adopted the use of the curtain for the second
experiment.
3.2. Second experiment
Histology conﬁrmed that a total of 66micehadaccuratebilateral
cannula placements in the DH (Fig. 2A). Therefore, the ﬁnal sample
sizes were as follows: SAL/SAL (n=8), SAL/CPA1 (n=9), SAL/CPA2
(n=10), SAL/CPA3 (n=8), LH/SAL (n=7), LH/CPA1 (n=8), LH/CPA2
(n=7), and LH/CPA3 (n=9).
3.2.1. Evaluation of the effects of l-histidine and
chlorpheniramine on anxiety (Trial 1)
ANOVA indicatedan interactionbetween i.p. and intra-DH injec-
tions for %OAE [F1 × F2(3,58) =3.48] and%OAT [F1 × F2(3,58) =3.46].
The Duncan’s test indicated that i.p. administration of LH (LH/SAL
group) increased both the %OAE and %OAT as compared with the
SAL/SAL group (Fig. 2C and D). ANOVA also indicated interac-
tions between treatments for %CT [F1 × F2(3,58) =2.84] and %pDips
[F1 × F2(3,58) =4.79] (Fig. 2F and G). The Duncan’s test indicated
that LH reduced %CT (a trend, p=0.052) and %pDips (Fig. 2F and
G) as compared with the control group. It is important to note that
these effectswereobserved in the absenceof any signiﬁcant change
in the frequency of EAE [F1 × F2(3,58) =1.54] (Fig. 2E).
Microinfusions of CPA into the DH did not alter the anxiety
indexes per se. However, when mice were previously treated with
LH, the three doses of CPA decreased %OAT (Fig. 2D) and increased
%pDips (at doses of 0.052 and 0.16nmol) and %CT (at dose of
0.16nmol) (Fig. 2F and G) as compared with the LH/SAL group.
3.2.2. Evaluation of the effects of l-histidine and
chlorpheniramine on emotional memory (Trial 2 versus Trial 1)
ANOVA revealed signiﬁcant differences between trials for %OAE
[F3(1,58) =40.51]; however, no interaction between the factors
was found [F1 × F2 × F3(3,58) =0.31]. In contrast, ANOVA indicated
signiﬁcant differences for %OAT [F3(1,58) =50.46] and an interac-
tion between the factors [F1 × F2 × F3(3,58) =4.39]. The Duncan’s
test indicated a reduction in T2 for %OAE for the groups SAL/SAL,
SAL/CPA2, SAL/CPA3, LH/SAL and LH/CPA2 (Fig. 2C). For %OAT,
post hoc test indicated a reduction in T2 for the groups SAL/SAL,
SAL/CPA2, SAL/CPA3, LH/SAL and LH/CPA2 (Fig. 2D).
As shown in Fig. 2(E and G), ANOVA revealed signiﬁcant dif-
ferences for EAE [F3(1,58) =26.76] and %pDips [F3(1,58) =69.35],
although no interaction between the factors was observed
(F1 × F2 × F3(3,58) =0.32; F1 × F2 × F3(3,58) =1.89, respectively).
Signiﬁcant differences and interactions between factors were
revealed for %CT ([F3(1,58) =19.91]; [F1 × F2 × F3(3,58) =2.92) and
%pSAP ([F3(1,58) =15.38]; [F1 × F2 × F3(3,58) =3.59]). The Duncan’s
test indicated that the control group exhibited increased %pDips,
and the administration of LH (LH/SAL) resulted in increased %CT,
%pSAP, and %pDips (Fig. 2F–H).
Animals that received i.p. injections of SAL, only microinfu-
sions of the lower dose of CPA (SAL/CPA1) did not decrease %OAE
or %OAT (Fig. 2C and D). Intermediate and higher doses of CPA
increased%pDips (Fig. 2G); theSAL/CPA3groupdisplayed increased
EAE (Fig. 2E) and %pSAP (Fig. 2H). However, in animals previously
Fig. 1. Mice submitted to the EPM under different conditions: without or with an
opaque black curtain placed around the EPM.Data are reported asmean+SEMof the
percentage of: open arm entries (%OAE) (a), open arm time (%OAT); (b) and enclosed
arm entries (EAE) during Trial 1 (T1) and Trial 2 (T2). *p<0.05 for T2 compared to T1
of respective group; #p<0.05 for T1 versus T1 of without curtain group (Two-way
ANOVA test, followed by Duncan’s test).
treated with LH, the lower dose of CPA decreased %OAT (Fig. 2D)
and increased %pDips, whereas the intermediate dose decreased
%OAE (Fig. 2C) and increased EAE (Fig. 2E), %CT and %dDips (Fig. 2F
and G).
4. Discussion
It has been described in the literature that rodents may use
vision for spatial navigation and avoid open spaces [19]. There-
fore, the aim of the ﬁrst experiment was to investigate if animals
associate the aversiveness of the open arms of the EPM with envi-
ronmental cues and then use these to remember/avoid the open
arms on a second trial. In this sense, our data demonstrated that
the absence of environmental cues increased the exploration of the
open arms on T1. The presence of a curtain placed around the EPM
might have decreased the aversiveness of the open arms, although
animals could still distinguish between open and enclosed arms,
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Fig. 2. Schematic representation of sites of intra-dorsal hippocampus (intra-DH) infusions (adapted from Paxinos and Franklin, 2001). Sites outside the DH are represented
by black dots. (A) Experimental procedure. (B) Effects of i.p. LH injection (500mg/kg) and intra-DH infusion of SAL or CPA (0.016, 0.052 and 0.16nmol/0.1l). Data are
represented as mean+SEM on the percentage of: open arm entries (%OAE) (C) and open arm time (%OAT) (D); the enclosed arm entries (EAE) (E); the percentages of: center
time (%CT) (F), protected head dipping (%pDips) (G) and protected stretched-attend postures (%pSAP) (H) during Trial 1 (T1) and Trial 2 (T2). *p<0.05 for T2 compared to T1;
#p<0.05 for T1 versus Tl of SAL/SAL; @ p<0.05 for T1 versus T1 of LH/SAL (Three-way ANOVA test, followed by Duncan’s test).
as they decreased open-arm exploration in T2. A different result
was observed for animals exposed to the non-curtain condition. It
is possible that the open arms of the EPM were too aversive, which
may have inhibited the open-arm exploration levels in T1, impair-
ing the comparisonwith the exploration levels in T2. Basedon these
data, we adopted the use of the curtain for the second experiment.
Several studies have demonstrated that drugs that increase
open-arm activity are anxiolytic, whereas drugs that reduce open-
arm activity are anxiogenic [4,18]. In our study, mice treated with
LH (i.p.) and SAL (intra-DH) exhibited increased open-arm explo-
ration of the EPM in T1 as compared with the control group.
Open-arm activity was accompanied by a decrease in the risk
assessment behaviors; thus, displaying an anxiolytic-like effect for
LH.However, theanxiolytic-likeeffectwasnotobservedwhenmice
were treated with LH and chlorpheniramine in the DH.
An allocentric strategy may facilitate associations between the
environmental cues and the risks represented by the open arms. As
egocentric strategies encode locations related to the current posi-
tion of the subject and rely on idiothetic cues [17], in the present
study, the black curtain increases exploration of the open arms
through egocentric strategies. This may justify the higher number
of open-arm entries.
However, the open-arm exploration is still lower than the
enclosed arms, as the percentage of time spent in the open arms
was 36.49%. Furthermore, control mice spent almost 63% of the
time in protected areas in T1, which indicates that they identify the
open arms as an aversive location.
Our ﬁndings diverge fromstudies on anxiety-like behaviors per-
formed by our research group demonstrating that different doses
of LH had no effects on the anxiety-like behaviors of mice during
exposure to the EPM [12,27,28]. These contradictory effects can
be explained because mice were studied under different exper-
imental conditions. It is possible that under a higher emotional
situation, such as in the standard EPM [12,27,28], LH may not have
an anxiolytic-like effect. On the other hand, in a moderate emo-
tional state, as we observed in our ﬁrst experiment, LH has an
anxiolytic-like effect.
The results of the present paper demonstrate that animals
treatedwithLHandCPAdisplayeddecreasedopen-armexploration
time. Furthermore, the higher dose increased the %CT and %pDips
compared with the LH/SAL group, which indicates the reversal of
the anxiolytic-like effects caused by l-histidine.
It has been demonstrated that histamine microinjected into the
ventral hippocampus of rats has an anxiogenic-like effect [26], and
when it is microinjected into the DH of rats, histamine has an
anxiolytic-like effect that is mediated by H1 receptors [33]. Accord-
ing to our data, the doses of chlorpheniramine used did not change
the anxiety-like behavior indices per se. However, higher doses of
CPA reversed the anxiolytic-like behavior of LH in a robust manner,
which demonstrates that this effect may also be mediated by the
H1 DH receptors of mice during exposure to the EPM.
An interesting feature of the EPMconcerns the inﬂuence of prior
test experience with the apparatus on subsequent behavioral and
pharmacological responses related to memory derived from prior
experience [4]. Upon re-exposure to the EPM, the animals of the
control group decreased open-arm exploration; thus, demonstrat-
ing that they were able to remember the aversive characteristics
of the open arms, but animals treated with the lower dose of CPA
explored the open arms at a level similar to the T1, indicating emo-
tional memory impairment. However, the same behavioral proﬁle
was not observed when subjects were treated with CPA at doses of
0.052 and 0.16nmol/0.1l.
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Different effects have been reported in the literature concern-
ing the involvement of H1 antagonists in mnemonic processes.
Gianlorenc¸o et al. [12] revealed that i.p. CPA reversed the state-
dependent memory deﬁcits induced by l-histidine in mice during
re-exposure to the EPM. However, previous results demonstrated
that learning and memory in passive avoidance and active avoid-
ance tests were improved by histamine H1 agonists and were
inhibited by histamine H1 receptor antagonists, such as pyrilamine
and CPA [16]. Furthermore, Nakazato et al. [22] observed that pyril-
amine impaired the working memory performance of rats when
administered to the DH, and the effects of intra-hippocampal pyril-
amine were prevented by histamine H1 receptor agonist.
It is known that CPA possess antimuscarinic effects [32] as well
as binding afﬁnity to the serotonin (5-HT) transporter [31] and
inhibits the uptake of 5-HT [29]. Thus, the CPA memory impair-
ment would be expected in the highest doses of CPA. However, in
our data, only the lower dose of CPA impaired emotional memory.
In mice, stimulation of 5-HT2A receptors facilitates consolida-
tion and extinction of fear memory [34]. Considering the dense
distribution of 5-HT2A receptors in the hippocampus [5], it is
conceivable that activation of the 5-HT2A receptors facilitates
information transmission and retention and thereby inﬂuences
memory consolidation [34]. According to this theory, we propose
that when higher doses of CPA are microinjected intra-DH, in addi-
tion to binding to H1 receptors, the CPA molecules may bind to
5-HT transporters; thus, increasing the extracellular 5-HT levels in
the DH and blocking the impairment effects of higher doses of CPA.
Future study will be performed to test this hypothesis.
Different effects of the action of histamine on memory have
been reported. De Almeida and Izquierdo [9] demonstrated that
post-training intracerebroventricular administration of histamine
improved the retention test performance of step-down inhibitory
avoidance behavior in rats. In addition, histamine elicited an ame-
liorating effect on scopolamine-induced learning and memory
deﬁcits via histamine H1 receptors in mice subjected to the EPM
[21].
Recently, our group reported that histamine may act differ-
ently on memory according to the emotional component, anxiety
or fear. An impairment of the emotional memory consolidation via
H1 receptorswas observedwhen histaminewasmicroinjected into
the vermis cerebellar ofmice re-exposed to the EPM [13,14]. On the
other hand, intra-cerebellar microinjection of histamine enhanced
memory consolidation of inhibitory avoidance learning in mice via
H2 receptors [11].
In the present work, our results demonstrated that LH did not
impair emotional memory. It is possible that, as in the cerebellum,
hippocampal histamine may act distinctly according to the emo-
tional situation. This hypothesis will be tested in a future study.
Thus, the lack of environmental cues together with the evidence
of hippocampal histamine involvement in the processing of emo-
tional memory may be the factors responsible for the difference in
our results compared with those reported by previous studies con-
ducted in our laboratory [27,28]. The DH would be responsible for
the spatial component in the processing of emotional memory.
In conclusion, our results indicate an anxiolytic effect of LH that
is mediated by the H1 receptors present in the DH of mice. In
addition to this ﬁnding, we suggest that this type of histaminer-
gic receptor in the DH is involved in the disruption of emotional
memory.
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